A prospective observational cohort study to screen major depressive disorders in geriatric oncology—Comparison of different scales

A prospective observational cohort study to screen major depressive disorders in geriatric oncology—Comparison of different scales

Objective Systematic depression screening is recommended for older patients with cancer. The objective of this study was to evaluate the performance of three mood disorder screening scales frequently used in geriatric oncology to help in diagnosing major depressive disorder (MDD). Methods A prospect...

Full description

Saved in:
Bibliographic Details
Published in:European journal of cancer care Vol. 31; no. 4; pp. e13591 - n/a
Main Authors: Boudin, Guillaume, Solem Laviec, Heidi, Ghewy, Lauriane, Le Bon, Priscille, Lebaube, Soazig, Machavoine, Jean‐Luc, Denhaerynck, Julie, Morello, Remy, Beauplet, Bérengère
Format: Journal Article
Language:English
Published: Oxford Hindawi Limited 01-07-2022
Subjects:
aged
Cancer
Cohort analysis
depression
geriatric assessment
Geriatric psychiatry
Geriatrics
Medical screening
Mental depression
Mental disorders
Mood
mood disorders
neoplasms
Observational studies
Older people
Oncology
Patients
Questionnaires
Variance analysis
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Systematic depression screening is recommended for older patients with cancer. The objective of this study was to evaluate the performance of three mood disorder screening scales frequently used in geriatric oncology to help in diagnosing major depressive disorder (MDD). Methods A prospective multicentre study was conducted in patients 70 years of age and over with cancer, comparing three self‐report questionnaires: the 15‐item Geriatric Depression Scale (GDS‐15), the Hospital Anxiety and Depression Scale – Depression (HADS‐D) and the Distress Thermometer (DT). In the event of abnormal scores, a psychologist consultation was suggested and a reassessment of the patient's mood was planned within 3 weeks. Potential differences between initial abnormal screening score and confirmed MDD (according to the Diagnostic and Statistical Manual of Mental Disorders criteria [DSM‐5]) were assessed using variance analysis for each screening scale. Results Ninety‐three patients with a median age of 81 years (70–95) were included. Sixty‐six patients had at least one abnormal score on one of the screening scales. MDD was confirmed in 10 of the 36 reassessed patients. Analysis of ROC curves showed that the HADS‐D significantly predicted MDD (AUC = 0.760, IC95%: 0.603–0.917; p = 0.017), but not the GDS‐15 or the initial DT. Conclusion The HADS‐D could better detect MDD, to confirm in a larger sample.
Bibliography:Funding information
French National Institute for Cancer (INCa)
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ISSN:0961-5423
1365-2354
DOI:10.1111/ecc.13591